Telemanagement Data was gathered from people on one of three medications for type 2 diabetes – thiazolidinedione , sulfonylurea or metformin. They looked at whether a person had refilled their prescription as a guide to medication adherence. The African American ... and more »
Diabetes In Control One was an updated meta-analysis by Steven Nissen, MD, of the Cleveland Clinic, and colleagues, which found a significantly increased risk of MI with use of the drug , and the other was an analysis of FDA data that found a higher risk of a composite of ...
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
Family Practice News Digital Network The cardiac safety of rosiglitazone, a thiazolidinedione (TZD) marketed as Avandia by GlaxoSmithKline, has been mired in controversy for several years because of analyses of data showing that rosiglitazone may increase the risk of MI or death. The Food ...
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
Family Practice News Digital Network The cardiac safety of rosiglitazone, a thiazolidinedione (TZD) marketed as Avandia by GlaxoSmithKline, has been mired in controversy for several years because of analyses of data showing that rosiglitazone may increase the risk of MI or death. The Food ...
